(Q34314426)

English

Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopy (English)

1 reference

Europe PubMed Central

1 August 2017

0 references

fluorescence spectroscopy

0 references

author name string

Froelich-Ammon SJ

1

1 reference

Europe PubMed Central

1 August 2017

Patchan MW

2

1 reference

Europe PubMed Central

1 August 2017

Osheroff N

3

1 reference

Europe PubMed Central

1 August 2017

Thompson RB

4

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 June 1995

1 reference

Europe PubMed Central

1 August 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

1 August 2017

270

1 reference

Europe PubMed Central

1 August 2017

14998-15004

1 reference

Europe PubMed Central

1 August 2017

25

1 reference

Europe PubMed Central

1 August 2017

Biochemical basis for the interactions of type I and type II topoisomerases with DNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Catalytic function of DNA topoisomerase II.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Structure and function of type II DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA gyrase: structure and function.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Fluoroquinolone antimicrobial agents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

The molecular basis of quinolone action

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA topoisomerase poisons as antitumor drugs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA topoisomerases: essential enzymes and lethal targets

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA Modification and Cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Multimodal action of antitumor agents on DNA: the ellipticine series

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Phase II study of elliptinium acetate salvage treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in vitro.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

A yeast type II topoisomerase selected for resistance to quinolones. Mutation of histidine 1012 to tyrosine confers resistance to nonintercalative drugs but hypersensitivity to ellipticine.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA topoisomerase-targeting antitumor drugs can be studied in yeast

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Yeast DNA topoisomerase II is encoded by a single-copy, essential gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA topoisomerase II is required at the time of mitosis in yeast

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Stimulation of topoisomerase II mediated DNA cleavage at specific sequence elements by the 2-nitroimidazole Ro 15-0216.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

A pyrimido[1,6-a]benzimidazole that enhances DNA cleavage mediated by eukaryotic topoisomerase II: a novel class of topoisomerase II-targeted drugs with cytotoxic potential

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Decay of fluorescence emission anisotropy of the ethidium bromide-DNA complex. Evidence for an internal motion in DNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Interaction of ellipticine and an indolo[2,3b]-quinoxaline derivative with DNA and synthetic polynucleotides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Elliptinium acetate in metastatic breast cancer--a phase II study

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Molecular Interactions of DNA-Topoisomerase I and II Inhibitor with DNA and Topoisomerases and in Ternary Complexes: Binding Modes and Biological Effects for Intoplicine Derivatives

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Alkaloids of Ochrosia elliptica Labill.1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

DNA double-strand breaks in mammalian cells after exposure to intercalating agents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Phase II study of amonafide in advanced and recurrent sarcoma patients

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Phase fluorometric method for determination of standard lifetimes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Characterization of ellipticine binding to native calf thymus DNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.25.14998

21 January 2018

Identifiers

10.1074/JBC.270.25.14998

1 reference

Europe PubMed Central

1 August 2017

release_4lzb6ev7e5csjcb7nolncffc3i

1 reference

https://api.fatcat.wiki/v0/release/4lzb6ev7e5csjcb7nolncffc3i

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34314426&oldid=1842669965"